Paid Clinical Trials Montgomery

Discover 35 paid clinical trials in Montgomery, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 35

Omecamtiv MecarbilStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Recruiting

PHASE3

Sponsor:

Cytokinetics

Location:

Alexander City AL, Tullahoma TN, Ocala FL, Clearwater FLshow 14 more

Code:

NCT06736574

Conditions

Heart Failure

Heart Failure With Reduced Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Omecamtiv Mecarbil (OM)

Placebo

BenralizumabA Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Montgomery AL, Mobile AL, New Orleans LA, Ocala FLshow 25 more

Code:

NCT05692180

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Benralizumab

Placebo

CannabinoidsCannabinoids and Biological Reactivity to Stress

Recruiting

EARLY_PHASE1

Sponsor:

Auburn University

Location:

Auburn AL

Code:

NCT06430580

Conditions

Cannabis Use Disorder

Eligibility Criteria

Sex: All

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

Hydrocortisone Oral

Yohimbine Hydrochloride

Cornstarch Placebo 20mg

Cornstarch Placebo 54mg

KC002Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Recruiting

PHASE2

Sponsor:

KeraCure

Location:

Montgomery AL, South Miami FL, Washington DC, Clinton IAshow 17 more

Code:

NCT00330265

Conditions

Foot Ulcer

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KC-002

Conventional Wound Therapy

MilvexianA Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Alexander City AL, Birmingham AL, Atlanta GA, Cartersville GAshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Osteopathic TreatmentThe Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

Recruiting

Sponsor:

Edward Via Virginia College of Osteopathic Medicine

Location:

Auburn AL

Code:

NCT06471426

Conditions

Headache

Neck Pain

Eligibility Criteria

Sex: All

Age: 19 - 65

Healthy Volunteers: Not accepted

Interventions

Osteopathic Manipulative Treatment

AZD5462A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

Recruiting

PHASE2

Sponsor:

AstraZeneca

Location:

Alexander City AL, Knoxville TN, Chapel Hill NC, Richmond INshow 10 more

Code:

NCT06299826

Conditions

Chronic Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AZD5462

Placebo

Stress InterventionEvaluation of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users

Recruiting

PHASE1

Sponsor:

Auburn University

Location:

Auburn AL

Code:

NCT06085222

Conditions

Cannabis Use Disorder

Eligibility Criteria

Sex: All

Age: 18 - 30

Healthy Volunteers: Not accepted

Interventions

Emotional Engagement Distress Tolerance Intervention

Health Education Intervention

ZiltivekimabA Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting

PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Alexander City AL, Atlanta GA, Fairhope AL, Macon GAshow 160 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

TezepelumabA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Montgomery AL, Atlanta GA, Savannah GA, Little Rock ARshow 25 more

Code:

NCT06023589

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 5 - 11

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo